Jul 2026
Tim-3 Sustains Tumor Treg Stability and Function, Limiting Checkpoint Blockade Therapy Efficacy.
Evidence is provided that Tim3-expressing Treg are a promising target to modulate tumor-specific immune responses and are a promising target to modulate tumor-specific immune responses.
Hridesh Banerjee, Onyedikachi V Onyekachi, Hector M Nieves-Rosado et al.
· Cancer immunology research · 0 citations